InvestorsHub Logo
Followers 145
Posts 27566
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 3648

Thursday, 03/31/2022 8:05:49 AM

Thursday, March 31, 2022 8:05:49 AM

Post# of 3988
Protalix BioTherapeutics GAAP EPS of -$0.62 misses by $0.03, revenue of $38.35M beats by $0.76M

Mar. 31, 2022 6:52 AM ETProtalix BioTherapeutics, Inc. (PLX)

By: Niloofer Shaikh, SA News Editor

Protalix BioTherapeutics press release (NYSE:PLX): FY GAAP EPS of -$0.62 misses by $0.03.

Revenue of $38.35M (-39.0% Y/Y) beats by $0.76M.

Cash, cash equivalents and short-term bank deposits were approximately $39M at December 31, 2021.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News